论文信息 - Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal - 字舞流文

Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

J. Kleijnen | G. Worthy | M. Joore | B. Ramaekers | R. Riemsma | S. Grimm | D. Fayter | N. Armstrong | W. Witlox | C. Noake | X. Pouwels | S. Petersohn | Sabine E. Grimm | Willem J. A. Witlox